INS and MODY: Many cases of MIDY and MODY require insulin therapy, however, MODY 1 and MODY 3, caused by mutations in the transcription factors hepatocyte nuclear factor 4α (HNF4A) and 1α (HNF1A), respectively, can often improve insulin secretion with sulfonylurea treatment.